A Phase 1 interventional study of Motivational Enhancement Therapy /Adol and PW for parents and Motivational Enhancement Therapy for adolescents in Substance Use Disorder and Delinquency, sponsored by Oregon Research Institute. Completed at 1 site in United States. Open to participants aged 13 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-10-10.
Sponsored by Oregon Research Institute · Phase 1, Interventional, and Treatment
The purpose of this study is to evaluate two brief, sustainable interventions for a sample of 280 adolescents charged with an initial drug-related offense: Motivational Enhancement Therapy (MET) intervention for youth and the Parenting Wisely (PW) intervention for parents. Families are assessed for adolescent substance use, HIV-risk, recidivist substance-related offenses, treatment entry, and other areas of individual and family functioning.
It is expected that the combined MET+PW interventions will be more effective than a treatment-as-usual intervention (drug education group) for adolescents with parents not participating in PW.
Illicit substance use and related problems among adolescents has been consistently high over the past decade and remains one of the most pressing public health concerns in the United States. The objective of this study is to conduct a pilot investigation of the feasibility and effectiveness of two brief empirically based treatments for adolescent substance abuse when implemented as early interventions for youth arrested and charged with first- or second-offense possession of alcohol or drugs. The two examined interventions are Motivational Enhancement therapy (MET) and Parenting Wisely (PW).
Over a one-year period, 280 adolescents and their parents will be referred to the study by the Juvenile Justice Centers in two Oregon counties within the Portland metro area. Families will be randomized to one of four intervention conditions; youth will receive either MET or a drug education intervention (EDUC), and the PW intervention for parents is present or absent. Participants will be assessed for adolescent substance use, HIV-risk, recidivist substance-related offenses, treatment entry, and other areas of individual and family functioning at intake and at 3- and 6-month follow-ups.
2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.
This study's enrollment of 239 is above the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →Oregon Research Institute is the lead sponsor of 70 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Motivational Enhancement Therapy for adolescents, Parenting Wisely for parents
Other: Motivational Enhancement Therapy /Adol and PW for parents
Motivational Enhancement Therapy for adolescents
Other: Motivational Enhancement Therapy for adolescents
Drug Education for adolescents, Parenting Wisely for parents
Other: Drug Education for adolescents, Parenting Wisely for parents
Drug Education for adolescents
Other: Drug Education for adolescents
Motivational Enhancement Therapy for adolescents, Parenting Wisely for parents
Also known as: MET / PW
Motivational Enhancement Therapy for adolescents
Also known as: MET
Drug Education for adolescents, Parenting Wisely for parents
Also known as: EDUC / PW
Drug Education for adolescents
Also known as: EDUC
Adolescent Substance Use and Related Problems
The questionnaire used is called the Time Line Follow Back.
Time frame: Change from Baseline at 6 months
Dysfunctional Discipline Practices
The questionnaire used to obtain this information is called Parenting Scale.
Time frame: Change from Baseline at 6 months
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Research Institute